Search research articles
Contact Us
Filters
Showing results (141-150 of 151) with videos related to
Page
of 16
Sort By:
Nature Cancer
|
May 22, 2024
Author Correction: Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling
Ali Rezvan, Gabrielle Romain, Mohsen Fathi, et al.
Neuro-Oncology
|
March 11, 2020
Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma
Soumen Khatua, Laurence J N Cooper, David I Sandberg, et al.
Frontiers in Immunology
|
November 28, 2022
Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies
Harjeet Singh, Samer A Srour, Denái R Milton, et al.
Science Translational Medicine
|
August 16, 2019
Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
E Antonio Chiocca, John S Yu, Rimas V Lukas, et al.
Blood
|
April 28, 2016
Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL
Xiuli Wang, Leslie L Popplewell, Jamie R Wagner, et al.
Cancer Immunology, Immunotherapy : CII
|
October 30, 2020
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity
Simone Punt, Shruti Malu, Jodi A McKenzie, et al.
The New England Journal of Medicine
|
December 14, 2012
Cord-blood engraftment with ex vivo mesenchymal-cell coculture
Marcos de Lima, Ian McNiece, Simon N Robinson, et al.
The Journal of Clinical Investigation
|
August 3, 2016
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
Partow Kebriaei, Harjeet Singh, M Helen Huls, et al.
Blood
|
March 18, 2015
Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation
Uday Popat, Rohtesh S Mehta, Katayoun Rezvani, et al.
Nature Communications
|
April 5, 2016
A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer
Sherry Y Wu, Rajesha Rupaimoole, Fangrong Shen, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 151) with videos related to
Sort By:
Page
of 16
Nature Cancer
|
May 22, 2024
Author Correction: Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling
Ali Rezvan, Gabrielle Romain, Mohsen Fathi, et al.
Neuro-Oncology
|
March 11, 2020
Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma
Soumen Khatua, Laurence J N Cooper, David I Sandberg, et al.
Frontiers in Immunology
|
November 28, 2022
Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies
Harjeet Singh, Samer A Srour, Denái R Milton, et al.
Science Translational Medicine
|
August 16, 2019
Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
E Antonio Chiocca, John S Yu, Rimas V Lukas, et al.
Blood
|
April 28, 2016
Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL
Xiuli Wang, Leslie L Popplewell, Jamie R Wagner, et al.
Cancer Immunology, Immunotherapy : CII
|
October 30, 2020
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity
Simone Punt, Shruti Malu, Jodi A McKenzie, et al.
The New England Journal of Medicine
|
December 14, 2012
Cord-blood engraftment with ex vivo mesenchymal-cell coculture
Marcos de Lima, Ian McNiece, Simon N Robinson, et al.
The Journal of Clinical Investigation
|
August 3, 2016
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
Partow Kebriaei, Harjeet Singh, M Helen Huls, et al.
Blood
|
March 18, 2015
Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation
Uday Popat, Rohtesh S Mehta, Katayoun Rezvani, et al.
Nature Communications
|
April 5, 2016
A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer
Sherry Y Wu, Rajesha Rupaimoole, Fangrong Shen, et al.
Page
of 16